Financials Vitro, S.A.B. de C.V.

Equities

VITRO A

MXP9802B1093

Commodity Chemicals

End-of-day quote Mexican S.E. 06:00:00 2024-05-21 pm EDT 5-day change 1st Jan Change
9.15 MXN +0.77% Intraday chart for Vitro, S.A.B. de C.V. +3.51% -63.25%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,291 1,057 758.6 553.7 533.2 673.5
Enterprise Value (EV) 1 1,721 1,566 1,232 1,196 1,164 1,185
P/E ratio 7.98 x 16.6 x -16.7 x -5.21 x 29.8 x 5.23 x
Yield 3.87% - 2.25% 1.81% 5.62% -
Capitalization / Revenue 0.58 x 0.49 x 0.43 x 0.28 x 0.23 x 2.17 x
EV / Revenue 0.77 x 0.72 x 0.7 x 0.61 x 0.49 x 3.82 x
EV / EBITDA 4.65 x 5.81 x 6.53 x 6.62 x 4.95 x 28 x
EV / FCF 50.4 x 16.2 x 10.3 x 1,013 x 13.7 x -4.77 x
FCF Yield 1.98% 6.19% 9.7% 0.1% 7.32% -21%
Price to Book 0.88 x 0.74 x 0.58 x 0.46 x 0.44 x 1 x
Nbr of stocks (in thousands) 479,121 474,142 474,142 470,027 470,027 470,027
Reference price 2 2.694 2.230 1.600 1.178 1.134 1.433
Announcement Date 2/22/19 7/1/20 4/20/21 4/29/22 4/19/23 4/30/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 2,238 2,180 1,768 1,958 2,352 310.7
EBITDA 1 370.1 269.4 188.5 180.8 235 42.37
EBIT 1 252.8 154.3 65.25 57.18 116.4 28.03
Operating Margin 11.3% 7.08% 3.69% 2.92% 4.95% 9.02%
Earnings before Tax (EBT) 1 208.1 76.91 3.976 -82.04 44.78 151.3
Net income 1 161.7 64.11 -45.38 -106.6 17.86 128.9
Net margin 7.23% 2.94% -2.57% -5.45% 0.76% 41.48%
EPS 2 0.3375 0.1346 -0.0957 -0.2261 0.0380 0.2742
Free Cash Flow 1 34.15 96.9 119.4 1.181 85.14 -248.5
FCF margin 1.53% 4.44% 6.75% 0.06% 3.62% -80%
FCF Conversion (EBITDA) 9.23% 35.97% 63.35% 0.65% 36.23% -
FCF Conversion (Net income) 21.11% 151.14% - - 476.62% -
Dividend per Share 2 0.1044 - 0.0360 0.0213 0.0638 -
Announcement Date 2/22/19 7/1/20 4/20/21 4/29/22 4/19/23 4/30/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 430 509 473 642 631 512
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 1.162 x 1.889 x 2.51 x 3.553 x 2.683 x 12.08 x
Free Cash Flow 1 34.1 96.9 119 1.18 85.1 -249
ROE (net income / shareholders' equity) 11.4% 4.43% -3.33% -8.53% 1.44% 13.1%
ROA (Net income/ Total Assets) 5.8% 3.47% 1.43% 1.32% 2.86% 0.83%
Assets 1 2,787 1,850 -3,164 -8,102 625.6 15,437
Book Value Per Share 2 3.060 3.010 2.750 2.550 2.560 1.430
Cash Flow per Share 2 0.6100 0.4900 1.020 0.2300 0.2600 0.0800
Capex 1 154 160 96 96.8 154 16.1
Capex / Sales 6.87% 7.36% 5.43% 4.94% 6.56% 5.18%
Announcement Date 2/22/19 7/1/20 4/20/21 4/29/22 4/19/23 4/30/24
1USD in Million2USD
Estimates
  1. Stock Market
  2. Equities
  3. VITRO A Stock
  4. Financials Vitro, S.A.B. de C.V.